Dr. Yining Zhao is the Co-founder and Executive Chairman of Transcenta Holding, a world-class biotherapeutics company with fully-integrated capabilities in research, development, regulatory and manufacturing of biologics. Transcenta Holding consists of two companies, namely HJB and MabSpace.
Prior to his entrepreneurial career, Dr. Zhao has been working in the areas of Strategy Management, Business Development, Product Development and M&A at multinational biopharmaceutical companies for around 20 years. He was Executive Strategy Director of Global Commercial Operations at Amgen based in Thousand Oaks, California where he was leading the market entry strategy, business development and commercialization of biosimilars in 30 countries outside US and EU. Prior to Amgen, Dr. Zhao was the Asia Strategy Lead at Pfizer based in New York, overseeing the Asia strategy across small molecule, biologics and vaccine.
Currently, Dr. Zhao is the Chairman of Veritas Genetics Inc. and CEO of Intuition Biosciences Inc., which are also co-founded by him and respectively specializes in human genetic testing and microbiome therapy. Dr. Zhao received his B.S. in Pharmaceutical Sciences from Fudan University (Shanghai, China), Ph.D. in Analytical Chemistry from Ghent University (Ghent, Belgium), and MBA from Massachusetts Institute of Technology (Cambridge, USA). Yining has contributed more than 30 peer-reviewed publications and book chapters.